ABCG2 is an ATP-binding cassette (ABC) efflux transporter [6]–[8], and its overexpression in cultured cells was found to cause resistance to various clinically used anti-cancer drugs, such as topotecan and irinotecan [2], [9]. Here, ABCG2 is linked to cancer.